Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enzo Biochem (ENZ)
NYSE:ENZ
Holding ENZ?
Track your performance easily
ENZ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.96 - $1.50
Previous Close$0.97
Volume106.79K
Average Volume (3M)81.11K
Market Cap
$50.68M
Enterprise Value$1.74M
Total Cash (Recent Filing)$52.37M
Total Debt (Recent Filing)$3.43M
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Dec 11, 2024EPS EstimateN/A
Last Dividend Ex-Date
Nov 15, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)-0.51
Shares Outstanding52,244,074
10 Day Avg. Volume141,237
30 Day Avg. Volume81,107
Standard Deviation0.19
R-Squared0.04
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.92
Price to Sales (P/S)1.65
Price to Cash Flow (P/CF)-12.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.05
Enterprise Value/Gross Profit0.12
Enterprise Value/Ebitda-0.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Enzo Biochem News
PremiumCompany Announcements
Enzo Biochem Reports Revenue Growth Despite Losses
PremiumCompany Announcements
Enzo Biochem Board Member Resigns to Pursue New Opportunities
PremiumCompany Announcements
Enzo Biochem Enhances CFO Patricia Eckert’s Compensation Package
PremiumCompany Announcements
Enzo Biochem Executives Receive Raises and Equity RewardsPremiumCompany Announcements
Enzo Biochem Announces 2023 Annual Meeting Outcomes
PremiumCompany Announcements
Enzo Biochem Shareholders Elect Directors, Reject Exec PayPremiumCompany Announcements
Enzo Biochem Appoints New CEO and CFOOwnership Overview
10.86% Insiders
4.56% Mutual Funds
11.52% Other Institutional Investors
69.13% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ENZ FAQ
What was Enzo Biochem’s price range in the past 12 months?
Enzo Biochem lowest stock price was $0.96 and its highest was $1.50 in the past 12 months.
What is Enzo Biochem’s market cap?
Currently, no data Available
When is Enzo Biochem’s upcoming earnings report date?
Enzo Biochem’s upcoming earnings report date is Dec 11, 2024 which is in 18 days.
How were Enzo Biochem’s earnings last quarter?
Enzo Biochem released its earnings results on Oct 29, 2024. The company reported -$0.256 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.256.
Is Enzo Biochem overvalued?
According to Wall Street analysts Enzo Biochem’s price is currently Overvalued.
Does Enzo Biochem pay dividends?
Enzo Biochem pays a Notavailable dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Enzo Biochem dividends here
What is Enzo Biochem’s EPS estimate?
Enzo Biochem’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enzo Biochem have?
Enzo Biochem has 52,244,076 shares outstanding.
What happened to Enzo Biochem’s price movement after its last earnings report?
Enzo Biochem reported an EPS of -$0.256 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.942%.
Which hedge fund is a major shareholder of Enzo Biochem?
Currently, no hedge funds are holding shares in ENZ
---
Enzo Biochem Stock Smart Score
Company Description
Enzo Biochem
Enzo Biochem, Inc. engages in the development, manufacture and sale of technology solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians globally. It operates through the following segments: Enzo Clinical Laboratory Services, Enzo Life Sciences Products, and Enzo Therapeutics. The Enzo Clinical Laboratory Services segment includes clinical reference laboratory providing a wide range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. The Enzo Life Sciences Products segment manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. The Enzo Therapeutics segment develops multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, many of which are derived from the pioneering work of Enzo Life Sciences. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.
---
ENZ Earnings Call
Q1 2022
0:00 / 0:00
---
Technical Analysis
---